Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Changes in pneumococcal serotypes and antimicrobial resistance after introduction of the 13-valent conjugate vaccine in the United States.

Richter SS, Diekema DJ, Heilmann KP, Dohrn CL, Riahi F, Doern GV.

Antimicrob Agents Chemother. 2014 Nov;58(11):6484-9. doi: 10.1128/AAC.03344-14. Epub 2014 Aug 18.

2.

Antibacterial properties of the CFTR potentiator ivacaftor.

Reznikov LR, Abou Alaiwa MH, Dohrn CL, Gansemer ND, Diekema DJ, Stoltz DA, Welsh MJ.

J Cyst Fibros. 2014 Sep;13(5):515-9. doi: 10.1016/j.jcf.2014.02.004. Epub 2014 Mar 5.

3.

Concordance of nasal and diabetic foot ulcer staphylococcal colonization.

Haleem A, Schultz JS, Heilmann KP, Dohrn CL, Diekema DJ, Gardner SE.

Diagn Microbiol Infect Dis. 2014 May;79(1):85-9. doi: 10.1016/j.diagmicrobio.2014.01.014. Epub 2014 Jan 24.

4.

Continued emergence of USA300 methicillin-resistant Staphylococcus aureus in the United States: results from a nationwide surveillance study.

Diekema DJ, Richter SS, Heilmann KP, Dohrn CL, Riahi F, Tendolkar S, McDanel JS, Doern GV.

Infect Control Hosp Epidemiol. 2014 Mar;35(3):285-92. doi: 10.1086/675283. Epub 2014 Jan 29.

PMID:
24521595
5.

Activities of vancomycin, ceftaroline, and mupirocin against Staphylococcus aureus isolates collected in a 2011 national surveillance study in the United States.

Richter SS, Diekema DJ, Heilmann KP, Dohrn CL, Crispell EK, Riahi F, McDanel JS, Satola SW, Doern GV.

Antimicrob Agents Chemother. 2014;58(2):740-5. doi: 10.1128/AAC.01915-13. Epub 2013 Nov 18.

6.

Evaluation of pneumococcal serotyping by multiplex PCR and quellung reactions.

Richter SS, Heilmann KP, Dohrn CL, Riahi F, Diekema DJ, Doern GV.

J Clin Microbiol. 2013 Dec;51(12):4193-5. doi: 10.1128/JCM.01876-13. Epub 2013 Sep 11.

7.

Abundant DNase I-sensitive bacterial DNA in healthy porcine lungs and its implications for the lung microbiome.

Pezzulo AA, Kelly PH, Nassar BS, Rutland CJ, Gansemer ND, Dohrn CL, Costello AJ, Stoltz DA, Zabner J.

Appl Environ Microbiol. 2013 Oct;79(19):5936-41. doi: 10.1128/AEM.01752-13. Epub 2013 Jul 19.

8.

Pneumococcal serotypes before and after introduction of conjugate vaccines, United States, 1999-2011(1.).

Richter SS, Heilmann KP, Dohrn CL, Riahi F, Diekema DJ, Doern GV.

Emerg Infect Dis. 2013 Jul;19(7):1074-83. doi: 10.3201/eid1907.121830.

9.

In vitro activity of ceftaroline against clinical isolates of Streptococcus pneumoniae recovered in 43 U.S. medical centers during 2010-2011.

Doern GV, Diekema DJ, Heilmann KP, Dohrn CL, Riahi F, Richter SS.

Antimicrob Agents Chemother. 2012 Jun;56(6):3406-8. doi: 10.1128/AAC.00582-12. Epub 2012 Apr 9.

10.

Detection of Staphylococcus aureus isolates with heterogeneous intermediate-level resistance to vancomycin in the United States.

Richter SS, Satola SW, Crispell EK, Heilmann KP, Dohrn CL, Riahi F, Costello AJ, Diekema DJ, Doern GV.

J Clin Microbiol. 2011 Dec;49(12):4203-7. doi: 10.1128/JCM.01152-11. Epub 2011 Oct 5.

11.

Activity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates collected from 43 medical centers in the United States in 2009.

Richter SS, Heilmann KP, Dohrn CL, Riahi F, Costello AJ, Kroeger JS, Biek D, Critchley IA, Diekema DJ, Doern GV.

Antimicrob Agents Chemother. 2011 Sep;55(9):4154-60. doi: 10.1128/AAC.00315-11. Epub 2011 Jun 27.

12.

The ΔF508 mutation causes CFTR misprocessing and cystic fibrosis-like disease in pigs.

Ostedgaard LS, Meyerholz DK, Chen JH, Pezzulo AA, Karp PH, Rokhlina T, Ernst SE, Hanfland RA, Reznikov LR, Ludwig PS, Rogan MP, Davis GJ, Dohrn CL, Wohlford-Lenane C, Taft PJ, Rector MV, Hornick E, Nassar BS, Samuel M, Zhang Y, Richter SS, Uc A, Shilyansky J, Prather RS, McCray PB Jr, Zabner J, Welsh MJ, Stoltz DA.

Sci Transl Med. 2011 Mar 16;3(74):74ra24. doi: 10.1126/scitranslmed.3001868.

13.

Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth.

Stoltz DA, Meyerholz DK, Pezzulo AA, Ramachandran S, Rogan MP, Davis GJ, Hanfland RA, Wohlford-Lenane C, Dohrn CL, Bartlett JA, Nelson GA 4th, Chang EH, Taft PJ, Ludwig PS, Estin M, Hornick EE, Launspach JL, Samuel M, Rokhlina T, Karp PH, Ostedgaard LS, Uc A, Starner TD, Horswill AR, Brogden KA, Prather RS, Richter SS, Shilyansky J, McCray PB Jr, Zabner J, Welsh MJ.

Sci Transl Med. 2010 Apr 28;2(29):29ra31. doi: 10.1126/scitranslmed.3000928.

14.

BD Phoenix and Vitek 2 detection of mecA-mediated resistance in Staphylococcus aureus with cefoxitin.

Junkins AD, Lockhart SR, Heilmann KP, Dohrn CL, Von Stein DL, Winokur PL, Doern GV, Richter SS.

J Clin Microbiol. 2009 Sep;47(9):2879-82. doi: 10.1128/JCM.01109-09. Epub 2009 Jul 22.

15.

Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005.

Richter SS, Heilmann KP, Dohrn CL, Riahi F, Beekmann SE, Doern GV.

Clin Infect Dis. 2009 Feb 1;48(3):e23-33. doi: 10.1086/595857.

PMID:
19115971
16.

Accuracy of phenotypic methods for identification of Streptococcus pneumoniae isolates included in surveillance programs.

Richter SS, Heilmann KP, Dohrn CL, Riahi F, Beekmann SE, Doern GV.

J Clin Microbiol. 2008 Jul;46(7):2184-8. doi: 10.1128/JCM.00461-08. Epub 2008 May 21.

17.

Increasing telithromycin resistance among Streptococcus pyogenes in Europe.

Richter SS, Heilmann KP, Dohrn CL, Beekmann SE, Riahi F, Garcia-de-Lomas J, Ferech M, Goossens H, Doern GV.

J Antimicrob Chemother. 2008 Mar;61(3):603-11. doi: 10.1093/jac/dkm525. Epub 2008 Jan 24.

PMID:
18218647

Supplemental Content

Loading ...
Support Center